We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Australian biotech firm CSL will purchase Swiss pharmaceutical company Vifor Pharma for $11.7 billion in a deal set to close in mid-2022, the companies announced. Read More
The new team will support Joaquin Duato, the company’s current vice chairman, who is set to take the reins as CEO from Alex Gorsky after the new year. Read More
Pfizer announced that it will buy Park City, Utah-based Arena Pharmaceuticals for $6.7 billion, pumping up its portfolio of therapies for immuno-inflammatory diseases. Read More
Johnson & Johnson (J&J) has appointed new members to its executive committee ahead of splitting its pharmaceuticals and over-the-counter consumer products businesses within the next two years. Read More
Roche has partnered with Recursion to generate up to 40 new neuroscience and cancer therapies using the Utah-based biotech firm’s machine-learning drug discovery platform. Read More
In the U.S., an FDA advisory committee narrowly backed authorizing molnupiravir last week, but the agency has yet to approve the COVID-19 pill for emergency use. Read More